EHA 2025: Signs of Functional Cure for MCL in 25 Years Nordic Follow-Up Study

At EHA 2025, Professor Mats Jerkeman, MD, PhD, Lund University & Skåne University Hospital, presented 20 years follow-up data from the Nordic MCL2 and MCL3 trials. In this MEDtalk you can hear why the results according to Mats Jerkeman raising hope that a subset particularly those under 50 years old MCL patients could be considered cured.